Clinical Trial Update: Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children [Phase 4]

View source ↗

Summary

An extension study of pegylated somatropin in children with growth retardation due to endogenous growth hormone deficiency (Phase 4) is being conducted; the sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Short Stature

Drugs mentioned

• Pegylated Somatropin (pegylated human growth hormone)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Growth Retardation | Phase 4 | Status: UNKNOWN